XML 44 R27.htm IDEA: XBRL DOCUMENT v3.24.1
Organization and Basis of Presentation (Details Narrative) - USD ($)
12 Months Ended
Jun. 02, 2023
Dec. 31, 2023
Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Net loss   $ 5,087,029 $ 6,312,535
Cash used in operations   4,293,265 4,611,737
Cash   4,203,488 5,353,392
Contractual obligation   6,412,000  
Clinical Trial Agreements and Clinical Trial Monitoring Agreements [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Contractual obligation   6,344,000  
Common Stock [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Reverse stock split 1-for-10    
Net loss